Hair-Related Problems among Polycystic Ovarian Syndrome-Affected Teenage Girls
DOI:
https://doi.org/10.5281/zenodo.20112042Abstract
Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrine disorders affecting adolescent girls, with onset often occurring during the early reproductive years. It is a multifactorial condition characterized by a complex interplay among genetic predisposition, hormonal imbalance, and environmental influences. The hallmark features of PCOS include hyperandrogenism (excess production of male hormones), ovulatory dysfunction leading to menstrual irregularities, and polycystic ovarian morphology. During adolescence, diagnosis can be particularly challenging, as normal pubertal changes may overlap with PCOS features; however, persistent symptoms such as irregular cycles and clinical signs of androgen excess warrant careful evaluation. One of the most distressing aspects of PCOS in teenage girls is the presence of hair-related manifestations, which are primarily driven by elevated androgen levels. Hirsutism, characterized by excessive growth of coarse, dark hair in androgen-dependent areas such as the face, chest, and back, is a common complaint. It often leads to embarrassment, low self-esteem, and social withdrawal, especially in cultures where such features are stigmatized. The severity of hirsutism may vary, but even mild cases can significantly affect body image and confidence in adolescents. In addition to hirsutism, androgenic alopecia (female pattern hair loss) is another important concern. It presents as diffuse thinning of hair over the crown and frontal scalp due to the miniaturization of hair follicles under the influence of androgens. For teenage girls, hair loss can be particularly alarming, as it contrasts with societal expectations of thick, healthy hair and may lead to heightened anxiety and emotional distress. Early recognition and management are essential to prevent progression and to preserve hair density. Acne-related hair and scalp issues are also frequently observed in adolescents with PCOS. Increased sebum production, driven by androgen excess, can lead to oily scalp conditions, dandruff, and inflammatory acne lesions along the hairline and scalp. These dermatological manifestations further compound the psychosocial burden of the disorder. The visibility of these symptoms often makes them more distressing than metabolic abnormalities, as they directly affect physical appearance and peer interactions. Beyond the physical symptoms, the psychological impact of hair-related issues in PCOS should not be underestimated. Adolescence is a critical period for identity formation and self-image, and visible changes such as unwanted hair growth or hair loss can lead to anxiety, depression, and reduced quality of life. Many affected girls may avoid social situations, experience bullying, or develop negative body image perceptions. Therefore, a holistic approach to management is essential, incorporating not only medical treatment but also psychological support and counseling. Overall, hair-related manifestations in adolescent PCOS are not merely cosmetic concerns but significant clinical features that require timely recognition and comprehensive care. Early diagnosis, lifestyle modification, pharmacological interventions (such as hormonal therapy and anti-androgens), and dermatological treatments can help manage these symptoms effectively. Addressing both the physical and emotional aspects of the condition is crucial to improving long-term outcomes and enhancing the overall well-being of affected individuals. Objective: The primary objective of this study is to determine the prevalence and spectrum of hair-related problems among teenage girls diagnosed with polycystic ovary syndrome (PCOS). These hair-related manifestations include hirsutism, androgenic alopecia (female pattern hair loss), and acne-associated scalp or hair conditions. By identifying how frequently these conditions occur within this population, the study aims to highlight the burden of dermatological manifestations of PCOS during adolescence, a critical period marked by heightened sensitivity to physical appearance and self-image. A further objective is to classify and characterize the different types and severity of hair-related problems observed in these patients. Standardized clinical assessment tools, such as the modified Ferriman–Gallwey score for hirsutism and validated grading systems for androgenic alopecia and acne severity, may be utilized to ensure objective evaluation. This classification will help in understanding the distribution patterns and clinical presentation of these manifestations in teenage girls with PCOS. In addition, the study seeks to assess the association between hair-related problems and key clinical parameters, including age, body mass index (BMI), menstrual irregularities, and the presence of other signs of hyperandrogenism. Evaluating these relationships will provide insight into whether certain clinical profiles are more strongly linked with specific hair disorders, thereby aiding in early identification and risk stratification of affected individuals. Another important objective is to examine the correlation between hair-related manifestations and hormonal profiles in adolescents with PCOS. Hormonal parameters, including serum testosterone, dehydroepiandrosterone sulfate (DHEAS), luteinizing hormone (LH), follicle-stimulating hormone (FSH), and insulin levels, will be analyzed. This will help determine whether the severity or type of hair-related issues is associated with the degree of hormonal imbalance, particularly hyperandrogenism and insulin resistance, which are central to PCOS pathophysiology. Finally, the study aims to provide a comprehensive understanding of the clinical and endocrine determinants of hair-related problems in teenage girls with PCOS. The findings may contribute to improved screening strategies, earlier diagnosis, and targeted management. By linking dermatological manifestations with underlying hormonal and metabolic disturbances, this research can support a more integrated and patient-centered approach to PCOS care in adolescents. Methods:: A descriptive cross-sectional study was conducted in the Department of Dermatology and Gynecology at a tertiary care hospital over 6 months. The study included 120 teenage girls aged 13–19 years who were diagnosed with PCOS using the Rotterdam criteria. Hair-related problems were clinically assessed. Hirsutism was evaluated using the Ferriman-Gallwey score, and alopecia was identified through clinical evaluation. Hormonal profiles, including serum testosterone and the LH/FSH ratio, were also recorded. Data were collected using a structured proforma—a standardized form for consistent data recording. This form captured demographic information, menstrual history, and family history of PCOS (polycystic ovary syndrome) or endocrine (hormone-related) disorders. Relevant clinical features were also noted. Anthropometric measurements, including height, weight, and body mass index (BMI), were recorded using standardized techniques. Each participant underwent a detailed dermatological exam (skin and hair assessment). The exam identified the presence and severity of hirsutism (excess hair growth in women), androgenic alopecia (a type of hair loss), and other scalp- or hair-related conditions. All assessments were performed by trained clinicians to ensure consistency and minimize observer bias (differences in results caused by the assessor). Venous blood samples were collected aseptically for hormonal analysis. Serum testosterone and the LH/FSH ratio were measured using standard laboratory methods. Samples were preferably collected in the early follicular phase or at a consistent time in irregular cycles to reduce hormonal variability. All laboratory investigations were conducted in the hospital's diagnostic laboratory while following quality control protocols to ensure accuracy and reliability. The collected data were entered and analyzed using statistical software such as SPSS. Descriptive statistics, including mean, standard deviation, frequencies, and percentages, summarized the data. Associations between hair-related problems and clinical or hormonal factors were assessed using the chi-square test and the independent t-test. A p-value of less than 0.05 was considered statistically significant. Ethical approval was obtained from the institutional review board. Informed consent was taken from all participants or their guardians before the study began. Results: Among participants, hirsutism was identified in 58%, androgenic alopecia in 32%, and diffuse hair thinning in 45%. Elevated serum testosterone correlated strongly with the severity of hair-related symptoms (p < 0.01). Psychological distress related to hair loss was present in 62% of patients. The severity of hirsutism, as measured by the Ferriman–Gallwey score, was directly correlated with elevated LH/FSH ratios and higher body mass index (BMI), clarifying that endocrine changes often manifest in specific hair disorders. Specifically, individuals with increased BMI were more likely to show moderate to severe hirsutism and extensive hair thinning than those with normal BMI. Similarly, androgenic alopecia was more prevalent among participants with chronic menstrual irregularities and increased androgen concentrations, further underscoring the link between endocrine dysregulation and observable hair-related symptoms. Additionally, a substantial proportion of patients reported a diminished quality of life due to hair-related issues. Low self-esteem, social avoidance, and embarrassment were frequently reported, especially among those with noticeable facial or scalp hair. Psychological distress was markedly higher among participants with more severe symptoms, emphasizing that the impact of PCOS extends beyond somatic manifestations. These findings underscore the necessity of incorporating psychological evaluation and intervention into comprehensive care for adolescents with PCOS. Conclusion: Hair-related problems are common among teenage girls with PCOS and demonstrate a strong link to hyperandrogenism and hormonal imbalance. Symptoms such as hirsutism, androgenic alopecia, and hair thinning clearly indicate endocrine disturbances and act as key markers for disease severity. Their high prevalence underscores the need for routine dermatological assessment in PCOS evaluations for adolescents. Early diagnosis and a multidisciplinary approach involving dermatologists, gynecologists, and mental health professionals are crucial for addressing both the physical and psychological impacts of the disease. Prompt intervention, encompassing hormonal management, lifestyle changes, and counseling, can substantially improve clinical outcomes, boost self-esteem, and enhance quality of life. Additionally, these findings stress the value of early screening for hair-related symptoms in adolescent girls with suspected PCOS. As these signs are often visible and particularly distressing, they can enable timely diagnosis and treatment. Incorporating regular hormonal and dermatological assessments into practice can support early detection of high-risk individuals and help prevent both cosmetic and metabolic complications. There is also a need to increase awareness and education among patients, families, and healthcare providers about PCOS's effects on physical appearance and mental health. Dispelling misconceptions, reducing stigma, and encouraging open discussion about these issues can promote treatment adherence and patient satisfaction. Future research should employ larger, multicenter studies to investigate the relationship between hormonal imbalance and dermatological symptoms and to assess targeted therapies to improve long-term outcomes. Keywords: PCOS, hirsutism, alopecia, teenage girls, hyperandrogenism, hair disorders




